In a brief talk, Bachelet said DNA nanobots will soon be tried in a critically ill leukemia patient. The patient, who has been given roughly six months to live, will receive an injection of DNA nanobots designed to interact with and destroy leukemia cells—while causing virtually zero collateral damage in healthy tissue. According to Bachelet, …
Very promising core-shell nanoparticle platform employs a hydrophobic interior comprising PLGA, a block copolymer of lactic and glycolic acids—both natural metabolic products—and diagnostic and therapeutic cargo molecules. Some PLGA molecules are linked to a fluorescent dye to track the disposition of the nanoparticles in animals. Encapsulated with the PLGA are molecules of a 25-amino acid …
A research team from The Scripps Research Institute (TSRI), Mayo Clinic and other institutions has identified a new class of drugs called “senolytics” that in animal models dramatically slows the aging process—alleviating symptoms of frailty, improving cardiac function and extending a healthy lifespan. “We view this study as a big, first step toward developing treatments …
Across China, only one million eligible families applied to have a second child under the newly relaxed policy, just a third of the number authorities had expected. “A lot of women working in high-competitive jobs look like they are less likely to have a second child,” Professor Zheng ZhenZhen of the Chinese Academy of Social …
Italian surgeon Sergio Canavero announce a project perform a human head transplant at a keynote lecture at the American Academy of Neurological and Orthopaedic Surgeons annual conference this June. He sees the procedure as being possible as soon as 2017 and believes it should be pursued as a means of saving people with, say, multi-organ …
In 1999, the U.S. Food and Drug Administration approved rapamycin as a drug for transplant patients. Sehgal died a few years after the FDA approval, too soon to see his brainchild save the lives of thousands of transplant patients and go on to make Wyeth hundreds of millions of dollars. Nextbigfuture has dozens of articles …
At the British Friends of Bar-Ilan University’s event in Otto Uomo October 2014 Professor Ido Bachelet announced the beginning of the human treatment with nanomedicine. He indicates DNA nanobots can currently identify cells in humans with 12 different types of cancer tumors. A human patient with late stage leukemia will be given DNA nanobot treatment. …
BBC News reports that a paralysed man has been able to walk again after a pioneering therapy that involved transplanting cells from his nasal cavity into his spinal cord. BBC One’s Panorama programme had unique access to the project and spent a year charting the patient’s rehabilitation. Darek Fidyka, 40, from Poland, was paralysed after …
The total number of confirmed , probable, and suspected cases) in the West African epidemic of Ebola virus disease (EVD) reported up to the end of 5 October 2014 (epidemiological week 40) was 8033 with 3865 deaths. The update for two weeks later is below but it has not provided an update on Liberia. Liberia …
Swiss scientists severed the spinal cords of a half-dozen rats and then implanted flexible electrodes into the lower part of their spinal cords. The animals were also given a type of drug known as a serotonin agonist, which Courtine says readies the spinal cord to communicate with the legs, an ability that’s depleted after an …
This article is part of the ‘Think Further’ series, sponsored by Fred Alger Management, Inc. For more ‘Think Further’ content and videos, visit thinkfurtheralger.com To understand the future of medicine in 2064, we have to understand what the current state of world health and life expectancy is in the world today, what has the largest …